Sensitive antibody-based CTCs detection from peripheral blood
dc.contributor.author | Shahneh, FZ | |
dc.date.accessioned | 2018-08-26T09:34:31Z | |
dc.date.available | 2018-08-26T09:34:31Z | |
dc.date.issued | 2013 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57748 | |
dc.description.abstract | The detection of Circulating Tumor Cells (CTC) is a purpose in numerous oncology research fields. CTCs are disseminated from the original site from metastatic and primary tumors in the peripheral blood of breast, prostate, lung and colorectal cancer patients. Different characteristics of tumor cells have been applied to define enrichment methods through the differential expression of tumor-specific markers on the surface of the cells. Antibody-based affinity methods can provide the separation of CTCs via the expression of specific antigens on the surface of epithelial tumor cells or hematopoietic cells. Developments in CTC detection methods will improve a wide range of clinical applications, as well as the discovery of biomarkers to predict treatment responses and disease progression. In this mini-review, different CTCs detection approaches base on antibodies for enrichment of circulating tumor cells will be discussed and elucidated the methods for CTCs detection biomarkers on the current knowledge. © 2013 - IOS Press and the authors. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | Human Antibodies | |
dc.subject | antibody | |
dc.subject | biological marker | |
dc.subject | cancer antibody | |
dc.subject | CD45 antigen | |
dc.subject | cell adhesion molecule | |
dc.subject | EPCAM protein, human | |
dc.subject | PTPRC protein, human | |
dc.subject | tumor antigen | |
dc.subject | tumor marker | |
dc.subject | antigen expression | |
dc.subject | article | |
dc.subject | binding affinity | |
dc.subject | blood | |
dc.subject | breast cancer | |
dc.subject | cancer recurrence | |
dc.subject | cell separation | |
dc.subject | cell surface | |
dc.subject | circulating tumor cell | |
dc.subject | colorectal cancer | |
dc.subject | disease course | |
dc.subject | epithelium cell | |
dc.subject | hematopoietic cell | |
dc.subject | human | |
dc.subject | lung cancer | |
dc.subject | metastasis | |
dc.subject | primary tumor | |
dc.subject | priority journal | |
dc.subject | prostate cancer | |
dc.subject | protein expression | |
dc.subject | treatment response | |
dc.subject | tumor cell | |
dc.subject | antibody specificity | |
dc.subject | cytology | |
dc.subject | gene expression | |
dc.subject | genetics | |
dc.subject | hematopoietic stem cell | |
dc.subject | immunology | |
dc.subject | immunomagnetic separation | |
dc.subject | Neoplasms | |
dc.subject | pathology | |
dc.subject | tumor cell line | |
dc.subject | tumor embolism | |
dc.subject | Antibodies, Neoplasm | |
dc.subject | Antigens, CD45 | |
dc.subject | Antigens, Neoplasm | |
dc.subject | Cell Adhesion Molecules | |
dc.subject | Cell Line, Tumor | |
dc.subject | Gene Expression | |
dc.subject | Hematopoietic Stem Cells | |
dc.subject | Humans | |
dc.subject | Immunomagnetic Separation | |
dc.subject | Neoplasms | |
dc.subject | Neoplastic Cells, Circulating | |
dc.subject | Organ Specificity | |
dc.subject | Tumor Markers, Biological | |
dc.title | Sensitive antibody-based CTCs detection from peripheral blood | |
dc.type | Article | |
dc.citation.volume | 22 | |
dc.citation.issue | 2 | |
dc.citation.spage | 51 | |
dc.citation.epage | 54 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.3233/HAB-130270 |
فایلهای درون آیتم
فایلها | سایز | فرمت | نمایش |
---|---|---|---|
هیچ فایل مرتبطی وجود ندارد |